Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Humble and Fred April8 2021
View:
Post by Marky1 on Apr 13, 2021 10:43pm

Humble and Fred April8 2021

Google that.  And see a Great interview Of Dan and Joe...at. 1.06 into it...Zoom link....They are amazing!
Comment by WalkOverTheStrt on Apr 14, 2021 8:30am
It was nice to see that the podhosts could relate to the issues on pain mgmt / repercussions and that one of them took Toradol (bad side effects). More PRs and interviews Antibe, keep them coming!
Comment by MrMugsy on Apr 14, 2021 9:18am
Same here - I liked the telling stories. I think one of them was even involved with using Vioxx at one point. You know ... if there are that many stories of NSAID overuse in one room ... you know there is a lot of gut damage out there.   It only complicates  and builds barriers to healthy living.  Nothing but problems as we get older. A couple things I said going into P2B ...more  
Comment by Arbourmark on Apr 14, 2021 10:31am
Unfortunately patience is not something generally associated with retail investors hence the current SP of $4.60 which represents pre split price of .46 cents just .06 higher then what it traded before $100 M Chinese partnership and then we raised additional funds and took all risk off the table to demonstrate we have the funding to complete phase 3. We have slowly dipped lower the last 3 ...more  
Comment by Hideaway on Apr 14, 2021 12:02pm
I've been invested in ate for years and and agree that one has to have patience with junior biotechs.However,my expectations was that we would see a bit more upward share price by now.Meeting timelines and transparency are the two categories that I look for when determining what action to take with juniors.I am somewhat disappointed with ate in achieving these markers.But,the science is ...more  
Comment by WalkOverTheStrt on Apr 15, 2021 7:46am
@Hideaway - at what stage gates are you waiting for / timelines wherein you will decide to continue to hold or add or sell? What if for example PH3 start pushed to Q2 2022?
Comment by Hideaway on Apr 15, 2021 8:41am
As I stated, I like the science but will not hold any junior biotech that fails to meet what I consider does not achieve major milestones or are less than my expectations for transparency.
Comment by Amigo11 on Apr 15, 2021 7:04pm
Thanks for the history lesson Arbourhole.Great to hear you think it will be ok .Phew !
Comment by Arbourmark on Apr 16, 2021 8:06am
once again Amigo decides to reply my post. He last reply he referred to me as a moron, this time he changes my name from Arbourmark to Arbourhole. Do you have nothing better to do then attack me with childish insults. Why don't you simply add beneficial content and posts for this board versus attacking posters.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities